+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Tyrosine Kinase Inhibitors Market 2025-2029 - Product Thumbnail Image

Tyrosine Kinase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 195 Pages
  • Global
From
End Stage Renal Disease (ESRD) Drug Market Report 2026 - Product Thumbnail Image

End Stage Renal Disease (ESRD) Drug Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Stem Cell Therapy Market Report and Forecast 2025-2034 - Product Thumbnail Image

Stem Cell Therapy Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Oncology API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oncology API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
Chronic Myeloid Leukemia Treatment Market Report 2025 - Product Thumbnail Image

Chronic Myeloid Leukemia Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Insulin Sensitizers Market - Global Strategic Business Report - Product Thumbnail Image

Insulin Sensitizers Market - Global Strategic Business Report

  • Report
  • April 2026
  • 340 Pages
  • Global
From
From
From
Loading Indicator